Skip to main content
. 2013 Aug 6;8(8):e70542. doi: 10.1371/journal.pone.0070542

Table 2. Characteristics of the Study Population, medication, n (%).

BMI
Medication < 25 kg/m2 n=5 (%) 25-30 kg/m2 n=7 (%) > 30 kg/m2 n=14 (%) P for difference
Renin-Angiotensin-Blockers 3 (60%) 5 (71%) 13 (93%) n.s.
Statins 3 (60%) 6 (86%) 10 (71%) n.s.
Antiplatelets 4 (80%) 6 (86%) 12 (86%) n.s.
Diuretics 3 (60%) 3 (43%) 11 (79%) n.s.
Calcium Channel Blockers 3 (60%) 3 (43%) 7 (50%) n.s.
Beta-Blockers 4 (80%) 4 (57%) 11 (79%) n.s.